Technology transfer, patent rights and funding, patent reform legislation. Issues related to pharmaceuticals and intellectual property protection. Education related to Hepatitis C International trade and protection of intellectual property Education related to HIV and Hepatitis C in American Indian population. Pending healthcare legislation and potential impact on the biopharmaceutical industry. Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing and treatment. HR.1628 American Health Care Act and S._ Better Care Reconciliation Act. HR.2212 and S.974 CREATES Act of 2017. HCV screening and linkage to care programs; coverage and reimbursement policy for HCV and HIV portfolio. HR.2430 and S.934 FDA Reauthorization Act; funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program; implementation of section 340B drug discount program. Prison population and hepatitis C. Ryan White Care Act reauthorization; Hepatitis C policy; HIV/AIDS research, testing and treatment. HR. 1628 American Health Care Act of 2017 and S._ Better Care Reconciliation Act; HCV testing, screening and linkage to care programs. HR. 2430 and S. 934, FDA Reauthorization Act. Federal program coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products. Coverage of pharmaceuticals, cost-sharing and other access issues; issues related to coverage and reimbursement of pharmaceuticals; FDA issues and 340B. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program. Coverage of pharmaceuticals, cost-sharing and other access issues. HR.2212 and S.974, CREATES Act of 2017. HR. 2430 and S. 934, FDA Reauthorization Act. HR. 1628 American Health Care Act and S. _ Better Care Reconciliation Act; issues related to coverage and reimbursement of pharmaceuticals; issues related to Medicare, Medicaid, and ACA implementation; FDA issues and 340B. Issues related to pharmaceuticals and international finance for health services. Intellectual property protection. Issues related to international and corporate tax reform
CPT - Copyright/Patent/Trademark VET - Veterans TRD - Trade (domestic/foreign) IND - Indian/Native American Affairs HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations PHA - Pharmacy FOR - Foreign Relations TAX - Taxation/Internal Revenue Code
34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 13 - Office of the Vice President of the United States 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 196 - U.S. Agency for International Development (USAID) 42 - Veterans Affairs, Dept of (VA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 13 - Office of the Vice President of the United States 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 196 - U.S. Agency for International Development (USAID) 42 - Veterans Affairs, Dept of (VA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 13 - Office of the Vice President of the United States 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 196 - U.S. Agency for International Development (USAID) 42 - Veterans Affairs, Dept of (VA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 13 - Office of the Vice President of the United States 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 196 - U.S. Agency for International Development (USAID) 42 - Veterans Affairs, Dept of (VA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 13 - Office of the Vice President of the United States 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 196 - U.S. Agency for International Development (USAID) 42 - Veterans Affairs, Dept of (VA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 13 - Office of the Vice President of the United States 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 196 - U.S. Agency for International Development (USAID) 42 - Veterans Affairs, Dept of (VA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 13 - Office of the Vice President of the United States 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 196 - U.S. Agency for International Development (USAID) 42 - Veterans Affairs, Dept of (VA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 13 - Office of the Vice President of the United States 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 196 - U.S. Agency for International Development (USAID) 42 - Veterans Affairs, Dept of (VA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 13 - Office of the Vice President of the United States 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 196 - U.S. Agency for International Development (USAID) 42 - Veterans Affairs, Dept of (VA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 13 - Office of the Vice President of the United States 1 - SENATE 39 - State, Dept of (DOS) 41 - Treasury, Dept of 196 - U.S. Agency for International Development (USAID) 42 - Veterans Affairs, Dept of (VA)
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE, FOSTER CITY, CA, 94404, US
DAVID PULLIAM DAVID PULLIAM DAVID PULLIAM KACY HUTCHISON DAVID PULLIAM KACY HUTCHISON DAVID PULLIAM KACY HUTCHISON DAVID PULLIAM KACY HUTCHISON DAVID PULLIAM KACY HUTCHISON DAVID PULLIAM KACY HUTCHISON DAVID PULLIAM KACY HUTCHISON KACY HUTCHISON